Healthcare / Medical Care FacilitiesSaudi
$5.90
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 25% · confianza 25%
FCF escenarios
weak_data · normalized FCF $9.7M · quality 72.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
58/100
C
Piotroski
4/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
8/100
SEC 0%
Sin guardar todavía.
Market Cap
$118M
P/E
14.8x
↓EV/EBITDA
8.9x
↓ROE
20.2%
↑Gross Margin
29.3%
↓Debt/Equity
0.04
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2024–2025 · 1 años de histórico normalizado
Revenue CAGR
+34.0%
FCF CAGR
+42.5%
FCF margin
25.0%
FCF / Net income
1.56x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $45.5M · net income $7.3M · FCF $11.4M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 |
|---|---|---|---|
| Income Statement | |||
| Revenue | $45.5M | $45.5M | $33.9M |
| Net Income | $7.3M | $7.3M | $6.3M |
| EBITDA | $9.0M | $9.0M | $7.1M |
| EPS | — | — | 0.32 |
| Gross Margin | 29.3% | 29.3% | 32.8% |
| Operating Margin | 17.8% | 17.8% | 20.6% |
| Net Margin | 16.1% | 16.1% | 18.6% |
| Balance Sheet | |||
| Debt/Equity | 0.04 | 0.04 | 0.05 |
| Current Ratio | 6.55 | 6.55 | — |
| Cash Flow | |||
| Free Cash Flow | $11.4M | $11.4M | $8.0M |
| Returns | |||
| ROE | 20.2% | 20.2% | 28.2% |
| Valuation | |||
| P/E | 14.75 | 14.75 | — |
| EV/EBITDA | 8.87 | 8.87 | — |
| P/B | 3.27 | 3.27 | — |
| Growth & Yield | |||
| Revenue Growth | 34.0% | 34.0% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+7.4%
Start / end P/E
n/dx → n/dx
EPS bridge
0.32 → n/d
Residual
+7.4%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.